Logo image of TR1.DE

T ROWE PRICE GROUP INC (TR1.DE) Stock Fundamental Analysis

FRA:TR1 - US74144T1088 - Common Stock

92.71 EUR
-3.41 (-3.55%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to TR1. TR1 was compared to 109 industry peers in the Capital Markets industry. TR1 is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. TR1 has a decent growth rate and is not valued too expensively. Finally TR1 also has an excellent dividend rating. With these ratings, TR1 could be worth investigating further for dividend investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

TR1 had positive earnings in the past year.
In the past year TR1 had a positive cash flow from operations.
Each year in the past 5 years TR1 has been profitable.
In the past 5 years TR1 always reported a positive cash flow from operatings.
TR1.DE Yearly Net Income VS EBIT VS OCF VS FCFTR1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

Looking at the Return On Assets, with a value of 13.85%, TR1 belongs to the top of the industry, outperforming 95.54% of the companies in the same industry.
TR1's Return On Equity of 18.81% is fine compared to the rest of the industry. TR1 outperforms 79.46% of its industry peers.
TR1's Return On Invested Capital of 13.25% is amongst the best of the industry. TR1 outperforms 91.07% of its industry peers.
The Average Return On Invested Capital over the past 3 years for TR1 is significantly above the industry average of 8.66%.
Industry RankSector Rank
ROA 13.85%
ROE 18.81%
ROIC 13.25%
ROA(3y)14.15%
ROA(5y)17.62%
ROE(3y)18.44%
ROE(5y)23.71%
ROIC(3y)15.27%
ROIC(5y)18%
TR1.DE Yearly ROA, ROE, ROICTR1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

TR1's Profit Margin of 27.99% is fine compared to the rest of the industry. TR1 outperforms 75.00% of its industry peers.
In the last couple of years the Profit Margin of TR1 has declined.
With a decent Operating Margin value of 32.45%, TR1 is doing good in the industry, outperforming 74.11% of the companies in the same industry.
TR1's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 32.45%
PM (TTM) 27.99%
GM N/A
OM growth 3Y-11.5%
OM growth 5Y-4.63%
PM growth 3Y-9.7%
PM growth 5Y-4.85%
GM growth 3YN/A
GM growth 5YN/A
TR1.DE Yearly Profit, Operating, Gross MarginsTR1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

9

2. Health

2.1 Basic Checks

The number of shares outstanding for TR1 has been reduced compared to 1 year ago.
Compared to 5 years ago, TR1 has less shares outstanding
TR1 has a better debt/assets ratio than last year.
TR1.DE Yearly Shares OutstandingTR1.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
TR1.DE Yearly Total Debt VS Total AssetsTR1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

TR1 has an Altman-Z score of 6.04. This indicates that TR1 is financially healthy and has little risk of bankruptcy at the moment.
TR1's Altman-Z score of 6.04 is amongst the best of the industry. TR1 outperforms 91.07% of its industry peers.
The Debt to FCF ratio of TR1 is 0.04, which is an excellent value as it means it would take TR1, only 0.04 years of fcf income to pay off all of its debts.
TR1 has a better Debt to FCF ratio (0.04) than 97.32% of its industry peers.
TR1 has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
TR1's Debt to Equity ratio of 0.00 is amongst the best of the industry. TR1 outperforms 88.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.04
Altman-Z 6.04
ROIC/WACCN/A
WACCN/A
TR1.DE Yearly LT Debt VS Equity VS FCFTR1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 2.81 indicates that TR1 has no problem at all paying its short term obligations.
TR1 has a Current ratio of 2.81. This is amongst the best in the industry. TR1 outperforms 85.71% of its industry peers.
TR1 has a Quick Ratio of 2.81. This indicates that TR1 is financially healthy and has no problem in meeting its short term obligations.
TR1's Quick ratio of 2.81 is amongst the best of the industry. TR1 outperforms 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 2.81
Quick Ratio 2.81
TR1.DE Yearly Current Assets VS Current LiabilitesTR1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 7.39% over the past year.
The Earnings Per Share has been growing slightly by 2.42% on average over the past years.
TR1 shows a small growth in Revenue. In the last year, the Revenue has grown by 4.43%.
Measured over the past years, TR1 shows a small growth in Revenue. The Revenue has been growing by 4.78% on average per year.
EPS 1Y (TTM)7.39%
EPS 3Y-9.91%
EPS 5Y2.42%
EPS Q2Q%-0.88%
Revenue 1Y (TTM)4.43%
Revenue growth 3Y-2.58%
Revenue growth 5Y4.78%
Sales Q2Q%-0.58%

3.2 Future

TR1 is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.10% yearly.
Based on estimates for the next years, TR1 will show a small growth in Revenue. The Revenue will grow by 1.47% on average per year.
EPS Next Y0.34%
EPS Next 2Y2.53%
EPS Next 3Y2.13%
EPS Next 5Y5.1%
Revenue Next Year1.22%
Revenue Next 2Y3.07%
Revenue Next 3Y2.95%
Revenue Next 5Y1.47%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TR1.DE Yearly Revenue VS EstimatesTR1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B
TR1.DE Yearly EPS VS EstimatesTR1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 11.84 indicates a reasonable valuation of TR1.
Based on the Price/Earnings ratio, TR1 is valued a bit cheaper than 77.68% of the companies in the same industry.
TR1's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.06.
A Price/Forward Earnings ratio of 11.06 indicates a reasonable valuation of TR1.
Based on the Price/Forward Earnings ratio, TR1 is valued cheaper than 83.93% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.69. TR1 is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.84
Fwd PE 11.06
TR1.DE Price Earnings VS Forward Price EarningsTR1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, TR1 is valued cheaply inside the industry as 81.25% of the companies are valued more expensively.
75.00% of the companies in the same industry are more expensive than TR1, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 20.34
EV/EBITDA 8.1
TR1.DE Per share dataTR1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
TR1 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)34.57
PEG (5Y)4.9
EPS Next 2Y2.53%
EPS Next 3Y2.13%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.56%, TR1 is a good candidate for dividend investing.
TR1's Dividend Yield is a higher than the industry average which is at 6.20.
TR1's Dividend Yield is rather good when compared to the S&P500 average which is at 2.45.
Industry RankSector Rank
Dividend Yield 4.56%

5.2 History

On average, the dividend of TR1 grows each year by 10.37%, which is quite nice.
Dividend Growth(5Y)10.37%
Div Incr Years2
Div Non Decr Years2
TR1.DE Yearly Dividends per shareTR1.DE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

57.43% of the earnings are spent on dividend by TR1. This is a bit on the high side, but may be sustainable.
The dividend of TR1 is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP57.43%
EPS Next 2Y2.53%
EPS Next 3Y2.13%
TR1.DE Yearly Income VS Free CF VS DividendTR1.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
TR1.DE Dividend Payout.TR1.DE Dividend Payout, showing the Payout Ratio.TR1.DE Dividend Payout.PayoutRetained Earnings

T ROWE PRICE GROUP INC

FRA:TR1 (9/5/2025, 7:00:00 PM)

92.71

-3.41 (-3.55%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-01 2025-08-01/bmo
Earnings (Next)10-30 2025-10-30/amc
Inst Owners79.48%
Inst Owner ChangeN/A
Ins Owners1.67%
Ins Owner ChangeN/A
Market Cap20.37B
Analysts49.47
Price Target90.22 (-2.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.56%
Yearly Dividend4.34
Dividend Growth(5Y)10.37%
DP57.43%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.77%
Min EPS beat(2)2.66%
Max EPS beat(2)2.88%
EPS beat(4)3
Avg EPS beat(4)2.05%
Min EPS beat(4)-5.31%
Max EPS beat(4)7.98%
EPS beat(8)6
Avg EPS beat(8)5.63%
EPS beat(12)10
Avg EPS beat(12)5.14%
EPS beat(16)10
Avg EPS beat(16)2.02%
Revenue beat(2)0
Avg Revenue beat(2)-2.59%
Min Revenue beat(2)-2.98%
Max Revenue beat(2)-2.2%
Revenue beat(4)0
Avg Revenue beat(4)-3.58%
Min Revenue beat(4)-4.82%
Max Revenue beat(4)-2.2%
Revenue beat(8)2
Avg Revenue beat(8)-2.63%
Revenue beat(12)3
Avg Revenue beat(12)-1.82%
Revenue beat(16)3
Avg Revenue beat(16)-2.81%
PT rev (1m)0.98%
PT rev (3m)8.59%
EPS NQ rev (1m)2.55%
EPS NQ rev (3m)0.19%
EPS NY rev (1m)7.14%
EPS NY rev (3m)11.53%
Revenue NQ rev (1m)3.06%
Revenue NQ rev (3m)-2.28%
Revenue NY rev (1m)1.84%
Revenue NY rev (3m)3.93%
Valuation
Industry RankSector Rank
PE 11.84
Fwd PE 11.06
P/S 3.36
P/FCF 20.34
P/OCF 15.54
P/B 2.26
P/tB 3.13
EV/EBITDA 8.1
EPS(TTM)7.83
EY8.45%
EPS(NY)8.39
Fwd EY9.05%
FCF(TTM)4.56
FCFY4.92%
OCF(TTM)5.97
OCFY6.44%
SpS27.62
BVpS41.09
TBVpS29.57
PEG (NY)34.57
PEG (5Y)4.9
Profitability
Industry RankSector Rank
ROA 13.85%
ROE 18.81%
ROCE 17.79%
ROIC 13.25%
ROICexc 17.33%
ROICexgc 27.49%
OM 32.45%
PM (TTM) 27.99%
GM N/A
FCFM 16.51%
ROA(3y)14.15%
ROA(5y)17.62%
ROE(3y)18.44%
ROE(5y)23.71%
ROIC(3y)15.27%
ROIC(5y)18%
ROICexc(3y)18.71%
ROICexc(5y)21.89%
ROICexgc(3y)30.22%
ROICexgc(5y)33.06%
ROCE(3y)20.58%
ROCE(5y)24.24%
ROICexcg growth 3Y-16.2%
ROICexcg growth 5Y-1.08%
ROICexc growth 3Y-13.37%
ROICexc growth 5Y-6.73%
OM growth 3Y-11.5%
OM growth 5Y-4.63%
PM growth 3Y-9.7%
PM growth 5Y-4.85%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.04
Debt/EBITDA 0.02
Cap/Depr 138.78%
Cap/Sales 5.1%
Interest Coverage 250
Cash Conversion 59.81%
Profit Quality 58.97%
Current Ratio 2.81
Quick Ratio 2.81
Altman-Z 6.04
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)130.91%
Cap/Depr(5y)124.54%
Cap/Sales(3y)4.8%
Cap/Sales(5y)4.19%
Profit Quality(3y)84.47%
Profit Quality(5y)86.86%
High Growth Momentum
Growth
EPS 1Y (TTM)7.39%
EPS 3Y-9.91%
EPS 5Y2.42%
EPS Q2Q%-0.88%
EPS Next Y0.34%
EPS Next 2Y2.53%
EPS Next 3Y2.13%
EPS Next 5Y5.1%
Revenue 1Y (TTM)4.43%
Revenue growth 3Y-2.58%
Revenue growth 5Y4.78%
Sales Q2Q%-0.58%
Revenue Next Year1.22%
Revenue Next 2Y3.07%
Revenue Next 3Y2.95%
Revenue Next 5Y1.47%
EBIT growth 1Y5.96%
EBIT growth 3Y-13.78%
EBIT growth 5Y-0.07%
EBIT Next Year-0.8%
EBIT Next 3Y3.03%
EBIT Next 5Y2.47%
FCF growth 1Y-9.3%
FCF growth 3Y-26.76%
FCF growth 5Y-0.86%
OCF growth 1Y-0.36%
OCF growth 3Y-21.25%
OCF growth 5Y2.05%